WHO Unit Head: Effectiveness of Monkeypox Vaccines Uncertain, Public Part of Clinical Trail 

Updated

By Jefferey Jaxen

During a live-streamed meeting of the World Health Organization’s (WHO) briefing on monkeypox. General-Director Tedros Adhanom Ghebreyesus declared the virus outbreak a public health emergency of international concern.    

The targeted states and communities where cases are clustering are being directed to vaccinate by public health officials in hopes of stoping the spread. However, a major concern was voiced during that same WHO meeting by Unit Head of Global Infectious Hazards Preparedness at the WHO Tim Nguyen, when he stated: 

“I would like to underline one thing that is very important to WHO. We do have uncertainties around the effectiveness of these vaccines because they haven’t been used in this context and this scale before. And therefore, we are working with our member states, that when these vaccines are being delivered, that they are delivered in the context of clinical trial studies and prospectively collecting this data to increase our understanding on the effectiveness of these vaccines.” 

On June 28, HHS announced they would provide 296,000 doses of Bavarian Nordic’s JYNNEOS vaccine. Then, on July 1 they announced an order of an additional 2.5 million doses of the FDA-licensed vaccine indicated for prevention of smallpox and monkeypox yet stated that deliveries from this latest order will begin arriving at the Strategic National Stockpile (SNS) later this year and will continue through early 2023.

In concurrence with Nguyen’s warning to the WHO, the CDC similarly states: “We do not know if JYNNEOS will fully protect against monkeypox virus infection in this outbreak. Individuals wanting to minimize their risk of infection should take additional preventive measures and self-isolate as soon as they develop monkeypox symptoms, such as a rash.”

The 2019 approval of the JYNNEOS vaccine by the FDA, a third-generation monkeypox vaccine, was in-part a response to the poor safety profile of the 2007 FDA-approved, second-generation ACAM2000 vaccine which produced higher rates of heart inflammation and was contraindicated in severely immunocompromised people. Concerning the ACAM2000, the CDC websites states

“Adverse events following ACAM2000, including myopericarditis or Vaccinia virus transmission to household contacts, can be serious. ACAM2000 will be made available for individuals who decide in consultation with their healthcare provider that the potential benefits of vaccination outweighs any potential risks from ACAM2000 adverse events.”

However, during two of the pivotal clinical trials evaluating the JYNNEOS vaccine, a significant number (18.4%) of subjects were reported to have abnormal troponin levels, a indicator that damage to the heart has occurred, following vaccination

The WHO first reported there was no evidence the monkeypox virus had mutated three weeks after the first case was identified in the UK. That proclamation soon gave way to reports of two distinct variants circulating on June 3 according to the CDC

Being a DNA virus, monkeypox has a more stable genetic code and a vastly slower mutation rate than the RNA-based coronavirus meaning variants aren’t produced as rapidly.

Jefferey Jaxen

Jefferey Jaxen is a health journalist and featured in his weekly segment, ’The Jaxen Report’, on The HighWire. As an investigative journalist, researcher, and compelling writer, Jefferey serves as Lead editor of The HighWire News and Opinion Team.

Other Headlines

Coronavirus

Senate hearing examines ‘available evidence’ on the origins of COVID-19

The Senate Homeland Security Governmental Affairs committee held a hearing and debate Tuesday morning regarding the origins of the COVID-19 pandemic. The hearing included two scientists who believe a zoonotic origin is the most likely explanation and two scientists who believe the virus was generated in a lab before leaking to the public. Gregory KoblentzContinue reading Senate hearing examines ‘available evidence’ on the origins of COVID-19

More news about Coronavirus

Health & Nutrition

Study Linking Raw Milk to H5N1 Mutations Sparks Controversy Over Pandemic Risks and Research Methods

A new study was released where the researchers inoculated raw milk with H5N1 (bird flu; avian flu), fed the milk to mice, and the mice became ill on the first day with “ruffled fur and lethargy.” The primary flaw with the study is that inoculated milk is different from milk that comes from an infectedContinue reading Study Linking Raw Milk to H5N1 Mutations Sparks Controversy Over Pandemic Risks and Research Methods

More news about Health & Nutrition

Vaccines

Kansas Sues Pfizer for Misleading Public on COVID-19 Vaccine Safety

Kansas has sued Pfizer for intentionally misleading the public about the safety and effectiveness of the COVID-19 vaccine. The state’s attorney general has detailed several grievances regarding Pfizer’s profit motives and attempts to bypass accountability from the government and/or the public. The suit alleges that Pfizer said the vaccine was safe but knew about seriousContinue reading Kansas Sues Pfizer for Misleading Public on COVID-19 Vaccine Safety

More news about Vaccines

Science & Tech

USDA Reopens Comment Period for Deregulation of Gene-Edited Plants

The deregulation of gene-edited plants is on the USDA agenda, and the public comment period has been extended by 21 days. The comment page has yet to be posted on the Federal Register. CRISPR is a new technology that is being used in agriculture to modify plants. “New Gene Technologies” or NGTs are how big agricultural companies like Bayer areContinue reading USDA Reopens Comment Period for Deregulation of Gene-Edited Plants

More news about Science & Tech

Environment

Texas Farmers Sue EPA Over PFAS Contamination in Biosolid Fertilizers

Texas farmers are suing the EPA for failing to regulate Per- and polyfluoroalkyl substances (PFAS) chemicals in biosolids fertilizer, which has contaminated millions of acres of farmland. Public Employees for Environmental Responsibility (PEER), an environmental non-profit, is representing the farmer plaintiffs in the suit. The complaint alleges that the EPA neglected to provide regulations forContinue reading Texas Farmers Sue EPA Over PFAS Contamination in Biosolid Fertilizers

More news about Environment

Policy

BREAKING: WHO Pandemic Treaty Dead in Water as Member States Fail to Reach Agreement

WHO member states failed to come to an agreement on the terms of the pandemic treaty, meaning there is no chance it will be adopted at the World Health Assembly next week. This is great news for all freedom fighters who have worked hard to defeat this highly disturbing initiative that would have granted theContinue reading BREAKING: WHO Pandemic Treaty Dead in Water as Member States Fail to Reach Agreement

More news about Policy